Max Robotics — Global Service Robot Directory + US Certification

About

Jason L. Letran is a leading figure in Asian prostate cancer research, with a career dedicated to understanding and improving outcomes for patients across the region. His work centers on the epidemiology, clinical management, and disparities in prostate cancer, particularly through the landmark Asian Prostate Cancer (A-CaP) study. As a key contributor to this initiative, Letran helped establish a comprehensive, Asia-wide database to track patient diagnoses, treatments, and survival patterns, addressing critical gaps in regional data. His most cited paper, the "Report of the third Asian Prostate Cancer study meeting" (2018, 12 citations), synthesizes collaborative efforts to clarify how genetic, environmental, and healthcare factors influence disease presentation and progression in Asian men. This work has been instrumental in highlighting differences from Western populations, paving the way for tailored screening and treatment protocols. Letran’s contributions extend beyond data collection; he has been a driving force in fostering multinational collaborations that bridge clinical research and public health. His efforts have not only advanced scientific understanding but also empowered clinicians across Asia to adopt evidence-based practices, making a tangible impact on prostate cancer care in the region.